相关实验视频

Updated: Jan 13, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

通过MDM2放大,PROTAC可以选择性地准瘤细胞

Jiandong Chen¹, Zainab Fatima¹, Lihong Chen¹

¹Moffitt Cancer Center Tampa, FL United States.

Molecular cancer therapeutics

|January 10, 2026

概括

针对蛋白质分解的嵌合体 (PROTACs) 可以选择性地降解癌细胞. 在瘤中MDM2放大增强了PROTAC的疗效,这表明了向性癌症治疗方法.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药物发现药物发现药物发现

背景情况:

化向化体 (PROTACs) 是一种诱导向蛋白质降解的新疗法.
目前的PROTACs利用无处不在的表达E3链酶,限制了瘤的特异性.
参与p53通路的MDM2在某些癌症中表现出瘤特异性放大.

研究的目的:

调查MDM2作为PROTAC介导的癌症治疗的瘤特异性E3结合酶.
为了评估一个基准PROTAC (A1874) 针对BRD4与MDM2表达相关的有效性.

主要方法:

在不同的MDM2表达条件下分析PROTAC化合物A1874的活性.
评估PROTAC在具有MDM2放大和没有MDM2放大的癌细胞中的疗效.
与MDM2状态和p53通路活性相关的细胞毒性评估.

主要成果:

在p53-突变细胞中,PROTAC A1874的活性取决于p53-介导的MDM2诱导,并且在p53-突变细胞中不活跃.
使用MDM2放大功能的瘤细胞显示PROTAC的功效高出约12倍.
增强的细胞毒性与MDM2放大和过度表达相关.

结论:

在瘤中,MDM2的放大或过度表达可以通过PROTACs进行选择性向.
这一策略有望提高治疗效率,减少癌症治疗中的毒性.
针对MDM2的PROTACs代表了针对特定癌症类型的潜在精准医学方法.

更多相关视频

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...